Q3 2025 Earnings Call Transcript November 3, 2025 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS ...
Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of ...
Developed by Ascentage Pharma, olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent Biologics ...
Lithium prices declined 6% year-on-year in the quarter, but spot market prices increased by 16% in October, comp ...
Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced business updates and reported financial results ...
Westpac Banking Corporation ( OTCPK:WEBNF) Q4 2025 Earnings Call November 2, 2025 7:01 PM EST ...
Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsRobert DeVitaDavid Hung - Founder, President, CEO ...
LRC records revenue growth of 86% year-on-year during the quarter Lithium prices declined 6% year-on-year in the quarter, but spot market prices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback